CACNA1G

Chr 17AD

calcium voltage-gated channel subunit alpha1 G

Also known as: Ca(V)T.1, Cav3.1, NBR13, SCA42, SCA42ND

Voltage-sensitive calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division, and cell death. This gene encodes a T-type, low-voltage activated calcium channel. The T-type channels generate currents that are both transient, owing to fast inactivation, and tiny, owing to small conductance. T-type channels are thought to be involved in pacemaker activity, low-threshold calcium spikes, neuronal oscillations and resonance, and rebound burst firing. Many alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Sep 2011]

Primary Disease Associations & Inheritance

Spinocerebellar ataxia 42MIM #616795
AD
Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficitsMIM #618087
AD
1495
ClinVar variants
7
Pathogenic / LP
1.00
pLI score· haploinsufficient
0
Active trials
Clinical SummaryCACNA1G
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
7 Pathogenic / Likely Pathogenic· 258 VUS of 1495 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?LOEUF (Loss-of-function Observed/Expected Upper bound Fraction) is the upper bound of the 90% CI for LoF OE — the preferred gnomAD v4 metric. Lower = more intolerant to LoF. LOEUF < 0.35 = highly constrained.
0.21LOEUF
pLI 1.000
Z-score 7.95
OE 0.13 (0.090.21)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?Missense Z-score: standard deviations fewer missense variants observed vs. expected. Z > 3.09 (p < 0.001) = gene does not tolerate missense variation. OE missense < 0.6 is also considered constrained.
4.64Z-score
OE missense 0.66 (0.620.69)
963 obs / 1462.1 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?Shaded band = 90% confidence interval. Vertical tick = point estimate. Grey threshold line = gnomAD constraint cutoff for that variant class.
LoF OE?Ratio of observed to expected LoF variants. Upper CI bound (LOEUF) ≤ 0.35 = strong LoF constraint signal.0.13 (0.090.21)
00.351.4
Missense OE?Ratio of observed to expected missense variants. OE ≤ 0.6 = fewer missense variants than expected by chance.0.66 (0.620.69)
00.61.4
Synonymous OE?Control metric — synonymous variants are largely neutral and expected near OE = 1.0. Significant deviation may indicate annotation issues.0.95
01.21.6
LoF obs/exp: 13 / 97.9Missense obs/exp: 963 / 1462.1Syn Z: 0.98

ClinVar Variant Classifications

1495 submitted variants in ClinVar

Classification Summary

Pathogenic3
Likely Pathogenic4
VUS258
Likely Benign101
Benign6
Conflicting11
3
Pathogenic
4
Likely Pathogenic
258
VUS
101
Likely Benign
6
Benign
11
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
1
2
0
3
Likely Pathogenic
0
3
1
0
4
VUS
9
228
19
2
258
Likely Benign
0
16
35
50
101
Benign
0
1
3
2
6
Conflicting
11
Total92496054383

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

CACNA1G · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Gene2Phenotype Curations

CACNA1G-related developmental disorder with hypotonia, epilepsy, and cerebral/cerebellar atrophy

strong
ADLoss Of FunctionAltered Gene Product Structure
Dev. Disorders
G2P ↗
missense variant

CACNA1G-related intellectual developmental disorder

limited
ARLoss Of FunctionAbsent Gene Product
Dev. Disorders
G2P ↗

Gene2Phenotype curations · DECIPHER consortium patient cohort (public variants) · deciphergenomics.org

OMIM — Genotype-Phenotype Relationships

1 OMIM entry

Spinocerebellar ataxia 42

MIM #616795

Molecular basis of disorder known

Autosomal dominant

Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits

MIM #618087

Molecular basis of disorder known

Autosomal dominant
Clinical Literature
Landmark / reviewRecent case evidence
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →